Joel Schneider's Insider Trades & SAST Disclosures
Joel Schneider's most recent trade in Solid Biosciences Inc was a trade of 15,272 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on March 14, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joel Schneider.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Solid Biosciences Inc | Joel Schneider | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 14 Mar 2022 | 15,272 | 236,270 (0%) | 0% | 1.1 | 16,799 | Common Stock |
| Solid Biosciences Inc | Joel Schneider | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 1.10 per share. | 14 Mar 2022 | 15,232 | 251,542 (0%) | 0% | 1.1 | 16,755 | Common Stock |
| Solid Biosciences Inc | Joel Schneider | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 180,000 | 180,000 | - | - | Employee Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Joel Schneider | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 90,000 | 90,000 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Joel Schneider | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.84 per share. | 12 Mar 2021 | 11,699 | 268,774 (0%) | 0% | 8.8 | 103,452 | Common Stock |
| Solid Biosciences Inc | Joel Schneider | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.84 per share. | 12 Mar 2021 | 11,699 | 280,473 (0%) | 0% | 8.8 | 103,468 | Common Stock |
| Solid Biosciences Inc | Joel Schneider | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 15,000 | 15,000 | - | - | Employee Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Joel Schneider | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 11,500 | 295,615 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Joel Schneider | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 11,500 | 0 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Joel Schneider | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 6.14 per share. | 27 Jan 2021 | 3,443 | 292,172 (0%) | 0% | 6.1 | 21,145 | Common Stock |
| Solid Biosciences Inc | Joel Schneider | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 175,000 | 175,000 | - | - | Employee Stock Option (Right to Buy) | |
| Solid Biosciences Inc | Joel Schneider | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2020 | 11,500 | 288,156 (0%) | 0% | - | Common Stock | |
| Solid Biosciences Inc | Joel Schneider | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2020 | 11,500 | 11,500 | - | - | Restricted Stock Units | |
| Solid Biosciences Inc | Joel Schneider | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.42 per share. | 27 Jul 2020 | 4,041 | 284,115 (0%) | 0% | 2.4 | 9,776 | Common Stock |
| Solid Biosciences Inc | Joel Schneider | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 75,000 | 276,656 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges